HER2 testing by immunohistochemistry in breast cancer: A multicenter proficiency ring study
Background: Human epidermal growth factor receptor 2 (HER2) over-expression in breast cancer is associated with aggressive tumor behavior and predicts response to targeted therapy. Accurate HER2 result is paramount for optimal patient management. However, routine HER2 immunohistochemistry (IHC) test...
Saved in:
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Published: |
Wolters Kluwer Medknow Publications
2021
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/35637/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|